DIA 2021 Virtual Global Annual Meeting

Component Type: Forum
Level: Intermediate
CE: ACPE 1.00 Knowledge UAN: 0286-0000-21-567-L04-P; CME 1.00; IACET 1.00; RN 1.00

Regulators have a duty to oversee compliance with national and international regulations, which is often allied to supporting and encouraging innovation and ensuring regulatory burden on industry is appropriate. The inspection universe continues to grow, and the complexity of operations has increased with the adoption of new technologies and an increasing number of novel approaches to the development of medicines. As a result new and innovative approaches to inspections have to be developed. Sole reliance on physical inspections is becoming increasingly outdated and is often not the most effective use of resource for the Regulator or Industry. The development of inspection activities which are flexible, risk focused and do not put unnecessary burden on industry is an important consideration. Central to this aim is the development of remote inspection strategies and record sharing approaches that benefit the regulator and Industry alike. This session will explore these new approaches from a regulatory and industry perspective.

Learning Objectives

Explore novel methodologies for performing regulatory inspections that provide benefits to both Regulators and Industry, whilst ensuring the safety and quality of medicines; Assess the advantages and disadvantages of new inspection models from both sides of the fence with a focus on oversight, efficiency, and cost saving; Analyze and trial the use of new and established technologies to aid the conduct of remote inspections.

Chair

Paula Walker, MA

Speaker

Novel and Flexible Approaches to Monitoring Regulatory Compliance Across the GXP Environment: MHRA Perspective
Paula Walker, MA

Panelist
Lesley Graham

Panelist
Hiromichi Isaka, MPharm